Propionyl-coenzyme A carboxylase (PCC), a mitochondrial biotindependent enzyme, is essential for the catabolism of the amino acids Thr, Val, Ile and Met, cholesterol and fatty acids with an odd number of carbon atoms. Deficiencies in PCC activity in humans are linked to the disease propionic acidaemia, an autosomal recessive disorder that can be fatal in infants [1] [2] [3] [4] . The holoenzyme of PCC is an a 6 b 6 dodecamer, with a molecular mass of 750 kDa. The a-subunit contains the biotin carboxylase (BC) and biotin carboxyl carrier protein (BCCP) domains, whereas the b-subunit supplies the carboxyltransferase (CT) activity. Here we report the crystal structure at 3.2-Å resolution of a bacterial PCC a 6 b 6 holoenzyme as well as cryo-electron microscopy (cryo-EM) reconstruction at 15-Å resolution demonstrating a similar structure for human PCC. The structure defines the overall architecture of PCC and reveals unexpectedly that the a-subunits are arranged as monomers in the holoenzyme, decorating a central b 6 hexamer. A hitherto unrecognized domain in the a-subunit, formed by residues between the BC and BCCP domains, is crucial for interactions with the b-subunit. We have named it the BT domain. The structure reveals for the first time the relative positions of the BC and CT active sites in the holoenzyme. They are separated by approximately 55 Å , indicating that the entire BCCP domain must translocate during catalysis. The BCCP domain is located in the active site of the b-subunit in the current structure, providing insight for its involvement in the CT reaction. The structural information establishes a molecular basis for understanding the large collection of disease-causing mutations in PCC and is relevant for the holoenzymes of other biotin-dependent carboxylases, including 3-methylcrotonyl-CoA carboxylase (MCC) 5-7 and eukaryotic acetyl-CoA carboxylase (ACC) 8, 9 .
Propionyl-coenzyme A carboxylase (PCC), a mitochondrial biotindependent enzyme, is essential for the catabolism of the amino acids Thr, Val, Ile and Met, cholesterol and fatty acids with an odd number of carbon atoms. Deficiencies in PCC activity in humans are linked to the disease propionic acidaemia, an autosomal recessive disorder that can be fatal in infants [1] [2] [3] [4] . The holoenzyme of PCC is an a 6 b 6 dodecamer, with a molecular mass of 750 kDa. The a-subunit contains the biotin carboxylase (BC) and biotin carboxyl carrier protein (BCCP) domains, whereas the b-subunit supplies the carboxyltransferase (CT) activity. Here we report the crystal structure at 3.2-Å resolution of a bacterial PCC a 6 b 6 holoenzyme as well as cryo-electron microscopy (cryo-EM) reconstruction at 15-Å resolution demonstrating a similar structure for human PCC. The structure defines the overall architecture of PCC and reveals unexpectedly that the a-subunits are arranged as monomers in the holoenzyme, decorating a central b 6 hexamer. A hitherto unrecognized domain in the a-subunit, formed by residues between the BC and BCCP domains, is crucial for interactions with the b-subunit. We have named it the BT domain. The structure reveals for the first time the relative positions of the BC and CT active sites in the holoenzyme. They are separated by approximately 55 Å , indicating that the entire BCCP domain must translocate during catalysis. The BCCP domain is located in the active site of the b-subunit in the current structure, providing insight for its involvement in the CT reaction. The structural information establishes a molecular basis for understanding the large collection of disease-causing mutations in PCC and is relevant for the holoenzymes of other biotin-dependent carboxylases, including 3-methylcrotonyl-CoA carboxylase (MCC) [5] [6] [7] and eukaryotic acetyl-CoA carboxylase (ACC) 8, 9 .
PCCs catalyse the carboxylation of propionyl-CoA to produce D-methylmalonyl-CoA. These enzymes are found in organisms from bacteria to humans, with highly conserved amino-acid sequences. For example, the aand b-subunits of human PCC (HsPCC) and Ruegeria pomeroyi PCC (RpPCC) share 54% and 65% sequence identity, respectively ( Supplementary Figs 1 and 2 ). To simplify discussions, we have numbered residues in bacterial PCCs according to their equivalents in HsPCC. The BC and BCCP domains in the a-subunit are homologous to their equivalents in ACC and pyruvate carboxylase (PC), whereas the b-subunit is homologous to the CT domain of ACC. The active site of BC is formed by residues from its A and C (sub-)domains, whereas the B (sub-)domain forms a lid that can assume open and closed conformations [9] [10] [11] . The active site of CT is located at the interface of its dimer, and each CT contains two (sub-) domains, the N and C domains 9, 12 . In contrast to the wealth of information about these domains, little is known about how they are assembled into the holoenzyme of PCC (or ACC).
To prepare samples of the PCC holoenzyme for structural studies, the aand b-subunits were co-expressed in Escherichia coli using a bicistronic plasmid. We first obtained crystals of HsPCC but could not improve the diffraction beyond 5.5 Å resolution after extensive efforts. In addition, the crystals exhibited perfect twinning (space group R3). We then examined a collection of bacterial PCCs, and were able to produce crystals of RpPCC that diffracted to 3.3 Å resolution. However, these crystals were also perfectly twinned (space group P3). Finally, we discovered that a PCC chimaera, containing the a-subunit of RpPCC and the b-subunit of Roseobacter denitrificans PCC (RdPCC), produced crystals without twinning (space group P1), and we determined its structure at 3.2 Å resolution (Supplementary Table 1 ). RdPCC is a close homologue of RpPCC, with their b-subunits sharing 88% sequence identity ( Supplementary Fig. 2 ). The structure of the chimaera is essentially the same as that of the native RpPCC dodecamer (Supplementary Text) as well as that of the HsPCC holoenzyme (see below).
The structure of the a 6 b 6 PCC holoenzyme contains a central b 6 hexamer core, in the shape of a short cylinder with a small hole along its axis ( Fig. 1a ). This hexameric core can be considered as a trimer of b 2 dimers, with each dimer being formed by one subunit from each layer of the structure (Fig. 1b) . In contrast, the a-subunits are arranged as monomers on both ends of the b 6 core, far from the centre of the holoenzyme, with each a-subunit contacting primarily only one b-subunit (see below). There are no significant conformational differences among the six copies of the aand b-subunits of the holoenzyme (Supplementary Information).
We performed cryo-EM studies on HsPCC and obtained a threedimensional reconstruction at 15-Å resolution by single-particle analysis ( Supplementary Figs 3-6 ). The cryo-EM envelope is remarkably similar to the overall shape of the crystal structure ( Fig. 1c ). In fact, the atomic model can be readily fitted into the cryo-EM map, giving a cross-correlation value of 0.80, and only the BCCP domain appears to be in a somewhat different position ( Fig. 1d ). These studies demonstrate that the structure of HsPCC is highly similar to that of the bacterial enzyme.
An unexpected discovery from the crystal structure of the holoenzyme is that there is little direct contact between the BC domain in the a-subunit and the b-subunit ( Fig. 2a ). Instead, interactions with the b-subunit are primarily mediated by a hitherto unrecognized domain in the a-subunit, formed by residues 514-653 in the connection between the BC and BCCP domains ( Supplementary Fig. 1 ). We have named it the BT domain, as it mediates BC-CT interactions. The BT domain has well-defined electron density ( Supplementary  Fig. 7 ), suggesting that it is highly ordered in the holoenzyme. A total of 1,950 Å 2 of the surface area of each a-subunit is buried at the interface with the b-subunits. Only 200 Å 2 are contributed by the BC domain ( Fig. 2a ). In contrast, the BT domain contributes 1,300 Å 2 to the buried surface area with one b-subunit, and an additional 100 Å 2 with an adjacent b-subunit ( Fig. 2a ). Finally, the BCCP domain contributes 350 Å 2 to the interface (see below).
The BT domain contains a long helix (aV, Supplementary Fig. 1 ) at the amino (N) terminus, followed by an eight-stranded up-down b-barrel (b22-b29) that surrounds the N-terminal two-thirds of the helix ( Fig. 2a and Supplementary Fig. 8 ). The carboxy (C)terminal one-third of the helix and the long loop connecting to the first b-strand protrude from the b-barrel, and form a 'hook' that provides a major contact with the b-subunit ( Fig. 2b and Supplementary  Fig. 8 ). A second area of close contact with the b-subunit is mediated by a small helix (aW) at the end of the BT domain ( Fig. 2c and Supplementary Fig. 8 ), which projects away from the b-barrel ( Fig. 2a ). The BT domain does not have any close structural homologues in Protein Data Bank, based on an analysis with the program DaliLite 13 . Remarkably, however, the domain does share some structural similarity with the PC tetramerization (PT) domain, which helps mediate the tetramerization of PC (Supplementary Information and Supplementary Fig. 9 ) 14 .
Many residues are located in the interface between the aand bsubunits ( Supplementary Figs 1 and 2) , forming ion-pair, hydrogenbonding and hydrophobic interactions (Supplementary Information). Residues making important contributions to the interface are generally conserved or show conservative variations among the PCC enzymes ( Supplementary Figs 1 and 2) , consistent with our observations that HsPCC has a similar structure. Our mutagenesis data confirm the extensive nature of the a-b-subunit interface and suggest that the holoenzyme can withstand substantial disruptions in it (Supplementary Information and Supplementary Table 2 ).
Another unexpected discovery from the structure is that the BC domains are arranged as monomers in the PCC holoenzyme ( Fig. 1a ). Studies of the BC subunit of bacterial ACCs have shown a dimeric association [9] [10] [11] , which may be required for its activity 15 , although monomeric BC mutants are catalytically active 16 . A conserved dimeric association of the BC domain was also observed in PC 14, 17 . However, the BC domains in PCC are monomeric and, in fact, there are no contacts among the a-subunits in the holoenzyme (Fig. 1a ). Our structure defines the molecular basis for the lack of dimerization of the BC domain in PCC (Supplementary Information). A monomeric arrangement of the BC domains also has significant relevance for the holoenzyme of eukaryotic ACCs (see below).
The active site of the BC domain is conserved with that of E. coli BC, and all the residues that interact with the substrates of this reaction have essentially the same conformation in both structures ( Supplementary Fig. 10 ) 18 . Similarly, residues in the active site of CT, located at the interface of a b-subunit dimer (Fig. 3a) , are also conserved. The structure of this dimer is homologous to those of the Streptomyces coelicolor and Mycobacterium tuberculosis acyl-CoA carboxylase b-subunits 19, 20 and the 12S subunit of Propionibacterium shermanii transcarboxylase ( Supplementary Fig. 11 ) 21 , which also form similar hexamers. Weaker structural similarity is observed with the CT domain of yeast ACC 12 , the CT subunit of bacterial ACC 22 and the CT subunit of a bacterial sodium pump 23 , although these CT enzymes only form dimers. A helical sub-domain at the C terminus of the CT domain of yeast ACC is incompatible with the b 6 hexamer of PCC. Our structure reveals for the first time the relative positions of the BC and CT active sites in the holoenzyme, providing unprecedented insight into PCC catalysis. The distance between the two active sites in PCC is about 55 Å (Fig. 3a) ; consequently the entire BCCP domain must translocate during catalysis (Supplementary Information and Supplementary Fig. 12 ). A similar situation has been observed in the structure of PC, where the BC and CT active sites are separated by 75 Å 14, 17 . Our cryo-EM studies on HsPCC have provided direct experimental evidence that the BCCP domain can be located in different positions in the holoenzyme (Fig. 1d ). Residues 654-660, the linker between the BT and BCCP domains, have weak electron density and are exposed to the solvent in the current structure ( Fig. 1b ), suggesting that they are flexible and can facilitate the translocation.
Further insight into PCC catalysis is obtained from the binding of the BCCP domain and its associated biotin, with well-defined electron density ( Supplementary Fig. 13 ), in the CT active site (Fig. 3a) . The interface between BCCP and the b-subunit is small, with 350-Å 2 surface area burial. Only residues 693-697 around the biotinylation site (Lys 694) interact with the b-subunit, through hydrophobic interactions and one hydrogen bond ( Fig. 3b and Supplementary  Fig. 14) . This weak interaction should also help the BCCP domain to leave the CT active site and translocate to the BC active site during catalysis. labelled b2) is also shown. c, Detailed interactions between helix aW in the BT domain and the b-subunit. The view is related to that of a through a 90u rotation around the vertical axis. See Supplementary Fig. 8 for stereo versions of b and c.
The active site of CT is located in a deep canyon at the b-subunit dimer interface (Fig. 3c) . The a6 helix from the C domain of one subunit and the a6 helix from the N domain of the other subunit form the two walls of the canyon. Our structure shows that BCCP-biotin occupies one half of the canyon, interacting with the C domain of one subunit ( Fig. 3d and Supplementary Fig. 14) . Propionyl-CoA, the other substrate of this activity, is expected to occupy the other half of the canyon and interact with the N domain of the second b-subunit ( Fig. 3d) 12, 19, 21 , with the propionyl group located in the centre of the canyon (Fig. 3c) . Biotin is in a partly folded, unproductive conformation in the current structure (Fig. 3b) , although a conformational change in the side chain of Lys 694 and the valeryl group of biotin should readily bring the N19 atom into the proximity of propionyl-CoA for catalysis.
Both RpPCC and the RpPCCa-RdPCCb chimaera have a preference for propionyl-CoA over acetyl-CoA as the substrate (Supplementary Table 4 ). Earlier studies with Streptomyces coelicolor acyl-CoA carboxylase showed that residue Asp 422-equivalent to Asp 440 in HsPCC and RpPCC and Val 440 in RdPCC (in helix a5, Fig. 3d )-is important for discriminating between the two substrates 19 . However, equivalent mutations in PCCs-D440I for RpPCC and V440I for the RpPCCa-RdPCCb chimaera-did not change their substrate preference ( Supplementary Table 4 ). Residue 440 is about 10 Å away from the thiol group of CoA ( Fig. 3d ) and does not directly contribute to substrate binding. Other residues may also be improtant in determining the substrate preference of these enzymes.
The structure of the holoenzyme establishes a foundation for understanding the molecular basis of many disease-causing mutations in PCC ( Fig. 4 and Supplementary Table 3 ) 1-4 . Among these, only the R399Q mutation in the a-subunit directly disrupts a residue in the active site ( Supplementary Fig. 15 ). This side chain stabilizes the biotin enolate during BC catalysis ( Supplementary Fig. 10 ) 18 , and the mutation leads to a large loss in activity 18, 24 . Another mutation, G668R in the BCCP domain ( Fig. 4) , abolishes biotinylation. Many of the other mutations are detrimental to catalysis by destabilizing the enzyme and/or interfering with holoenzyme assembly 1, [25] [26] [27] . Many of them, especially those in the b-subunit, are actually located near the active site ( Supplementary Fig. 15 ), and they may indirectly affect substrate binding and/or catalysis as well. For example, the R165W and R165Q mutations may disturb the recognition of the adenine base of CoA ( Supplementary Fig. 15 ). On the other hand, few of the missense mutations are located in the interface between the aand b-subunits of the holoenzyme ( Fig. 4 and Supplementary 16 ). The extensive nature of this interface might make it difficult to disrupt the holoenzyme by single-site mutations in this region (Supplementary Information).
The structure of the PCC holoenzyme also has strong implications for the structure and function of other biotin-dependent carboxylases. There are five such enzymes in humans: PCC, MCC, ACC1, ACC2 and PC ( Supplementary Fig. 17 ). MCC is a close homologue of PCC, with the same domain architecture and subunit organization. Therefore the PCC structure is directly relevant for understanding the MCC enzyme and its disease-causing mutations [5] [6] [7] .
Most importantly, the identification of the BT domain in PCC led us to re-examine the sequences of eukaryotic, multi-domain ACCs. The segment containing the BC and BCCP domains in these enzymes is remarkably similar to the PCC a-subunit, with a linker of about 120 residues between the two domains ( Supplementary Fig. 17 ). Secondary structure prediction shows that this linker contains a helix followed by seven or more b-strands, suggesting that it may form a structure similar to the BT domain in PCC. This putative BT domain of ACC is likely also crucial for mediating interactions between its BC and CT domains. In fact, we have observed that purified BC and CT domains of yeast ACC do not interact with each other (unpublished results). Because the CT domain dimer of ACC is similar to the b 2 dimer of PCC, the a 2 b 2 assembly of PCC might be a plausible model for the organization of the ACC dimer, the protomer that can also form higher oligomers. This model implies that the BC domain could be monomeric in the ACC holoenzyme, which is consistent with observations that isolated BC domains of eukaryotic ACCs are monomeric in solution 28, 29 , in contrast to the dimers for bacterial BC subunits. Therefore, there might be a fundamental difference between the overall architecture of eukaryotic, multi-domain ACCs and that of bacterial, multi-subunit ACCs.
METHODS SUMMARY
Crystallography. The aand b-subunits of PCC were co-expressed in E. coli, with a His-tag on the b-subunit. The PCC holoenzyme was purified by nickelaffinity and gel-filtration chromatography. Crystals were obtained by the microbatch method under oil, and the structures were determined by the molecular replacement method. Cryo-EM. Frozen hydrated human PCC particles at 70 mg ml 21 concentration were imaged at 350,000 magnification in a 100-kV cryo-electron microscope. A featureless Gaussian oval was used to obtain a low-resolution (40-Å ) model from negative-stain electron microscope images. A 15-Å resolution three-dimensional reconstruction was obtained from approximately 10,000 cryo-EM particle images, using the structure from the negative stain images as the initial model. Mutagenesis and kinetic studies. Site-specific and deletion mutants were designed based on the structural information, and their effects on the formation of the holoenzyme were assessed by nickel-affinity chromatography. The catalytic activity of PCC was determined by a coupled enzyme assay, monitoring the hydrolysis of ATP. Structure of one a-subunit and one b 2 -subunit dimer of PCC, in the same view as Fig. 3a . The locations of the missense mutations associated with propionic acidaemia are indicated with the spheres, coloured by the domains. The BC and CT active sites are indicated with the stars.
